BRCA2 MUTATION

Clinical trials for BRCA2 MUTATION explained in plain language.

Never miss a new study

Get alerted when new BRCA2 MUTATION trials appear

Sign up with your email to follow new studies for BRCA2 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 12 Not yet finished but already full! 6 Completed 1 Terminated 1

New Triple-Threat treatment tested for tough breast cancers

Disease control Completed

This study tested whether combining three medications—olaparib, palbociclib, and fulvestrant—is safe for people with advanced breast cancer that is hormone-sensitive and has a BRCA gene mutation. The main goal was to check for side effects and see how long patients lived without …

Matched conditions: BRCA2 MUTATION

Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control

Last updated Mar 24, 2026 12:01 UTC

BRCA2 MUTATION

Get alerted when new BRCA2 MUTATION trials appear

New Triple-Threat treatment tested for tough breast cancers